Joe Gabler Appointed Chief Growth Office at Paytient

Paytient, the leading provider of health plan affordability solutions, announces today the addition of Joe Gabler as Chief Growth Officer. Joe Gabler is a senior executive and healthcare consumer payments pioneer with nearly 20 years of experience building companies around winning cultures. Joe will join Paytient to drive growth and expansion as the company continues to partner with leading employers, payers, and PBMs.

Serving over 5,000 enterprise partners with nearly 25 million lives moving into 2025, Paytient welcomes Joe to scale its partnerships with mid-market employers, large commercial groups, leading payers, and Medicare plan sponsors to make healthcare more easily accessible for millions more Americans in the coming years.

“The Medicare Prescription Payment Plan in 2025 means that smoothing out-of-pocket costs over time is becoming a standard of care for healthcare in the United States. Paytient is well positioned to serve as the leading platform giving Americans a better ability to access and afford care,” said Brian Whorley, Founder and CEO of Paytient. “As we prepare for the growth this will bring, Joe’s proven ability to scale teams and operations with winning cultures is a fantastic and critical addition to our leadership team.

Joe Gabler comments:

“Paytient is improving healthcare with a strategy that puts choice and affordability in the hands of members, knowing they need to be at the heart of real change. I’ve seen what can happen when people are empowered to care for their whole health, which is increasingly out of reach these days. I’m incredibly excited to join the amazing team at Paytient and passionately help expand the reach of this mission.”
Joe Gabler spent the first 13 years of his career helping SPS Commerce (SPSC) grow from a small business to a hugely successful IPO and multi-billion dollar market value. There he held multiple operations, strategy, and growth management positions. The next 6 years saw him reinventing the healthcare benefits landscape, leveraging innovative consumer payments strategies at Solutran, now acquired by Optum. They built a market-leading payment network serving over half the Medicare Advantage market and processing billions of dollars yearly in consumer benefit payments. Paytient is excited to welcome Joe onto its executive leadership team and leverage his expertise to pursue new growth opportunities.
SourcePaytient

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.